FDA Highlights Importance Of Computational Modeling
This article was originally published in The Gray Sheet
Executive Summary
During the Oct. 14 panel meeting, Bram Zuckerman, director of FDA’s Division of Cardiovascular Devices, emphasized the importance of computational modeling to further understand complex vascular regions like femoral arteries.